New Cogent Reports study reveals biopharmaceutical companies that administer Patient Assistance Programs (PAPs) exceptionally well can lead to more prescriptions for the cancer medications these companies manufacture.
Compared to their peers who represent mutual fund or variable annuity (VA) products, ETF wholesalers receive significantly lower ratings from advisors for two critical satisfaction measures: effectively demonstrating an understanding of an advisor's business, and recommending products that are well suited to an individual's practice.
While investment performance remains paramount, advisors are also placing greater importance on understanding, and recognizing, asset managers' unique investment processes or expertise in specific asset classes.
Despite declining fund use among advisors, traditional mutual fund managers, particularly large fund complexes, are positioned to play a leading role in the next phase of the ETF revolution, the rollout of active ETFs.
Signaling imminent change in the defined contribution (DC) investment marketplace, just over half (51%) of plan sponsors say they will modify their investment line-up over the next 12 months, which is up considerably from the 44% of sponsors that anticipated changes one year ago.
Apple and Samsung will only grow stronger in the near term, as more than 80 and 60 percent of their customers, respectively, say they will stay with them, according to a survey by Market Strategies International.